Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FR0NC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $88,386
Award facts
- Contract value 100% obligated
- $88,386.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $88,386.24 on January 21, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside contract is funded by the Defense Logistics Agency (DLA) and will be completed by January 22, 2026, with performance taking place at the contractor's Conshohocken facility. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 single-award vehicle through December 2031 that serves as the primary procurement mechanism for supplying comprehensive pharmaceutical products and medical supplies to military healthcare programs globally.
This delivery order falls within the scope of DLA's pharmaceutical supply chain supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Repatha is a specialty medication used for cholesterol management and cardiovascular disease prevention, reflecting the diverse therapeutic domains covered under the broader IDC vehicle. AmerisourceBergen's receipt of this award, consistent with its competitive contract portfolio, demonstrates the company's established capability to efficiently fulfill government requirements for essential pharmaceutical commodities required by military treatment facilities and federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FR0NC?
SPE2DR26FR0NC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FR0NC worth?
The government has obligated $88,386 on SPE2DR26FR0NC.
Is contract SPE2DR26FR0NC an order under another contract?
Yes. SPE2DR26FR0NC is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0NC competed?
The extent of competition for SPE2DR26FR0NC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award